ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1480

Risk of Ischemic Stroke in Sjögren’s Syndrome Patients: A Systematic Review and Meta-Analysis

Jirapat Teerakanok1, Daniel Cordoba2, Sakolwan Suchartlikitwong3 and Kenneth Nugent4, 1Internal medicine, Texas Tech University health and sciences center, Lubbock, TX, 2Internal Medicine, Texas Tech University Health and Sciences Center, Lubbock, TX, 3Internal medicine, Texas Tech University Health Sciences Center, Lubbock, TX, 4Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: cerebrovascular disease and meta-analysis, Sjogren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Sjögren's Syndrome Poster II: Clinical Research

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Primary Sjögren’s syndrome (SS) is an autoimmune disease of the exocrine glands with lymphocytic infiltration into lacrimal and salivary glands. Autoimmune diseases increase cardiovascular risk by premature vascular damage. There were observational studies on the risk of ischemic stroke in primary SS patients, but results have been inconclusive. We conducted a meta-analysis to compare incidence of ischemic stroke in SS and normal populations.

Methods: Two investigators searched published articles in EMBASE and PubMed database from 1980 to the end of February 2017 using the terms “Sjögren’s syndrome”, “ischemic stroke”, “stroke”, “cerebrovascular accident”, “cerebrovascular disease”, “cerebrovascular disorder”, “cerebral infarction”, “cerebral ischemia”, “brain infarction” and “brain ischemia”. Manual searching in the conferences abstract database from 2002-2016 was performed. Inclusion criteria were 1) observational studies (cohort, case control, cross sectional studies), 2) studies comparing incidence of ischemic stroke in SS and normal population, 3) studies providing relative risk (RR), odds ratio (OR), or standardized incidence ratio (SIR) with 95% confidence interval (CI). Quality assessment of studies was performed using Newcastle-Ottawa quality assessment scale. Review Manager 5.3 software was used to perform data analysis. Studies were combined by the generic inverse variance method described by Dersimonian and Laird. We used a random-effect model because of the variance in the studies. Cochran’s Q test was used to calculate I2 to measure heterogeneity across studies. A funnel plot was used to assess for publication bias.

Results: Five studies (3 cohort studies, 1 case control study, and 1 cross sectional study) were met our criteria with 9,514 patients with primary SS. The pooled risk ratio for ischemic stroke in primary SS patients compared to control populations was 1.21 (95% CI 0.97-1.50), heterogeneity was moderate with I2 of 60%, there was no evidence of publication bias from funnel plot.

Conclusion : We found no statistically significant increased risk for ischemic stroke in primary SS patients compared to the normal population, but more studies are needed to clarify the association between these two conditions.


Disclosure: J. Teerakanok, None; D. Cordoba, None; S. Suchartlikitwong, None; K. Nugent, None.

To cite this abstract in AMA style:

Teerakanok J, Cordoba D, Suchartlikitwong S, Nugent K. Risk of Ischemic Stroke in Sjögren’s Syndrome Patients: A Systematic Review and Meta-Analysis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/risk-of-ischemic-stroke-in-sjogrens-syndrome-patients-a-systematic-review-and-meta-analysis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-of-ischemic-stroke-in-sjogrens-syndrome-patients-a-systematic-review-and-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology